Progress in the role of endometrial glucose metabolism in embryo implantation
The synthesis and decomposition of glycogen adjust the blood glucose dynamically to maintain the energy supply required by the cells. As the only hormone that lowers blood sugar in the body, insulin can promote glycogen synthesis by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and increasing glucose transporter translocation, and inhibit gluconeogenesis to lower blood glucose. In the endometrium, glycogen metabolism is active, but gluconeogenesis does not occur. The glycogen metabolism in the endometrium is controlled not only by the classical glucose regulating hormones, but also by the ovarian hormones. The functional activities related to implantation of the endometrium during the implantation window require glucose as energy source. A large amount of glucose is used to synthesize glycogen in the endometrium before implantation, which could meet the increased energy demand for embryo implantation. In diabetes, glycogen metabolism in the endometrium is impaired, which frequently leads to implantation failure and early abortion. This article reviews the glycogen metabolism in the endometrium and discusses its role in embryo implantation, which provide new ideas for embryo implantation research and infertility treatment.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
---|---|
Enthalten in: |
Sheng li xue bao : [Acta physiologica Sinica - 74(2022), 2 vom: 25. Apr., Seite 255-264 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Ma, Yong-Dan [VerfasserIn] |
---|
Themen: |
9005-79-2 |
---|
Anmerkungen: |
Date Completed 05.05.2022 Date Revised 05.05.2022 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM340318074 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM340318074 | ||
003 | DE-627 | ||
005 | 20231226004858.0 | ||
007 | tu | ||
008 | 231226s2022 xx ||||| 00| ||chi c | ||
028 | 5 | 2 | |a pubmed24n1134.xml |
035 | |a (DE-627)NLM340318074 | ||
035 | |a (NLM)35503073 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Ma, Yong-Dan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Progress in the role of endometrial glucose metabolism in embryo implantation |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 05.05.2022 | ||
500 | |a Date Revised 05.05.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The synthesis and decomposition of glycogen adjust the blood glucose dynamically to maintain the energy supply required by the cells. As the only hormone that lowers blood sugar in the body, insulin can promote glycogen synthesis by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and increasing glucose transporter translocation, and inhibit gluconeogenesis to lower blood glucose. In the endometrium, glycogen metabolism is active, but gluconeogenesis does not occur. The glycogen metabolism in the endometrium is controlled not only by the classical glucose regulating hormones, but also by the ovarian hormones. The functional activities related to implantation of the endometrium during the implantation window require glucose as energy source. A large amount of glucose is used to synthesize glycogen in the endometrium before implantation, which could meet the increased energy demand for embryo implantation. In diabetes, glycogen metabolism in the endometrium is impaired, which frequently leads to implantation failure and early abortion. This article reviews the glycogen metabolism in the endometrium and discusses its role in embryo implantation, which provide new ideas for embryo implantation research and infertility treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Glycogen |2 NLM | |
650 | 7 | |a 9005-79-2 |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
700 | 1 | |a Wang, Yi-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Yue, Li-Min |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Sheng li xue bao : [Acta physiologica Sinica |d 1960 |g 74(2022), 2 vom: 25. Apr., Seite 255-264 |w (DE-627)NLM012651508 |x 0371-0874 |7 nnns |
773 | 1 | 8 | |g volume:74 |g year:2022 |g number:2 |g day:25 |g month:04 |g pages:255-264 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 74 |j 2022 |e 2 |b 25 |c 04 |h 255-264 |